Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Obinutuzumab in the treatment of B-cell malignancies: a comprehensive review.
Davies A, Kater AP, Sharman JP, Stilgenbauer S, Vitolo U, Klein C, Parreira J, Salles G. Davies A, et al. Among authors: parreira j. Future Oncol. 2022 Aug;18(26):2943-2966. doi: 10.2217/fon-2022-0112. Epub 2022 Jul 20. Future Oncol. 2022. PMID: 35856239 Free PMC article. Review.
Comparative effectiveness between mosunetuzumab monotherapy clinical trial and real-world data in relapsed/refractory follicular lymphoma in third or subsequent lines of systemic therapy.
McGough SF, Shamas N, Wang J, Jaber M, Swarup B, Blanchet Zumofen MH, Lautié B, Parreira J, Wei MC, Shewade A. McGough SF, et al. Among authors: parreira j. Leuk Lymphoma. 2023 Dec;64(14):2269-2278. doi: 10.1080/10428194.2023.2262066. Epub 2023 Dec 25. Leuk Lymphoma. 2023. PMID: 37840271 Free article.
Mosunetuzumab Safety Profile in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma: Clinical Management Experience From a Pivotal Phase I/II Trial.
Matasar M, Bartlett NL, Shadman M, Budde LE, Flinn I, Gregory GP, Kim WS, Hess G, El-Sharkawi D, Diefenbach CS, Huang H, To I, Parreira J, Wu M, Kwan A, Assouline S. Matasar M, et al. Among authors: parreira j. Clin Lymphoma Myeloma Leuk. 2024 Apr;24(4):240-253. doi: 10.1016/j.clml.2023.12.005. Epub 2023 Dec 12. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38195322 Free article. Clinical Trial.
Obinutuzumab Can Be Administered as a 90-minute Short Duration Infusion in Patients With Previously Untreated Follicular Lymphoma: GAZELLE End of Induction Analysis.
Canales MA, Buchholz TA, Bortolini JAP, Fogliatto LM, Ishikawa T, Izutsu K, Salar A, Sharman JP, Klingbiel D, Pokala S, Vorozheikina E, Trask P, Parreira J, Hübel K. Canales MA, et al. Among authors: parreira j. Hemasphere. 2023 Mar 30;7(4):e860. doi: 10.1097/HS9.0000000000000860. eCollection 2023 Apr. Hemasphere. 2023. PMID: 37008164 Free PMC article. No abstract available.
Penetrating cardiac injuries: What you need to know.
Parreira JG, Coimbra R. Parreira JG, et al. J Trauma Acute Care Surg. 2024 Dec 10. doi: 10.1097/TA.0000000000004524. Online ahead of print. J Trauma Acute Care Surg. 2024. PMID: 39670817
94 results